Leap Therapeutics's market cap is currently $19.30M. The company's EPS TTM is $-1.929; its P/E ratio is ―; Leap Therapeutics is scheduled to report earnings on March 24, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 1.50M	$ 1.50M	$ 0.00
Gross Profit	$ -427.00K	$ -415.00K	$ 1.50M	$ 1.50M	$ -776.00K
Operating Income	$ -87.04M	$ -56.76M	$ -41.43M	$ -28.54M	$ -33.45M
EBITDA	$ -80.99M	$ -53.98M	$ -40.01M	$ -26.81M	$ -32.10M
Net Income	$ -81.41M	$ -54.60M	$ -40.59M	$ -27.51M	$ -32.90M
Balance Sheet
Cash & Short-Term Investments	$ 70.64M	$ 65.50M	$ 114.92M	$ 52.07M	$ 3.89M
Total Assets	$ 72.83M	$ 70.35M	$ 117.91M	$ 54.37M	$ 7.45M
Total Debt	$ 262.00K	$ 678.00K	$ 469.00K	$ 552.00K	$ 1.03M
Net Debt	$ -70.38M	$ -64.82M	$ -114.45M	$ -51.52M	$ -2.87M
Total Liabilities	$ 12.68M	$ 11.49M	$ 10.02M	$ 7.72M	$ 9.20M
Stockholders' Equity	$ 60.14M	$ 58.87M	$ 107.89M	$ 46.65M	$ -1.75M
Cash Flow
Free Cash Flow	$ -43.75M	$ -49.04M	$ -35.16M	$ -25.96M	$ -27.00M
Operating Cash Flow	$ -43.75M	$ -49.04M	$ -35.16M	$ -25.96M	$ -26.90M
Investing Cash Flow	$ 48.97M	$ 0.00	$ 0.00	$ 25.00K	$ -85.00K
Financing Cash Flow	$ -30.00K	$ -210.00K	$ 98.03M	$ 74.00M	$ 14.82M

Currency in USD

Leap Therapeutics Earnings and Revenue History

Income Statement >

Leap Therapeutics Debt to Assets

Balance Sheet >

Leap Therapeutics Cash Flow

Cash Flow >

Leap Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing